Now showing items 1-6 of 6

    • Zemelman Decarli, Viviana; Valenzuela, Carlos Y.; Fisch, Félix; Road, Johanna; Honeyman Mauro, Juan (2003)
      Background: There is an increase in the incidence rates of skin cancer in Chile. Aim: To study the clinical diagnostic accuracy (CDA) for skin cancer. Material y methods: CDA was defined as the percentage of agreement ...
    • Zemelman Decarli, Viviana; Molina C, Paula; Valenzuela Yuraidini, Carlos; Honeyman Mauro, Juan (2008)
      Background: There is an increase in the incidence of malignant melanoma in Chile. Previous studies have shown that the density and size of acquired melanocytic nevi (AMN) are a risk factor for developing malignant melanoma. ...
    • Honeyman Mauro, Juan; Valdés, R.; Rojas, H.; Gaete, M. (2008)
    • Valdés Arrieta, María del Pilar; Schroeder, Francisca; Roizen G., Vicky; Honeyman Mauro, Juan; Sánchez M, Leonardo (2006)
      Background: Psoriasis has a moderate or severe course in 25% of patients, requiring systemic therapy that is not always successful. Infliximab is a human-murine monoclonal anti tumor necrosis alpha (TNF- a) antibody. This ...
    • Honeyman Mauro, Juan; Honeyman, Ana Robles; De la Parra, Marco A.; Pinto, Alicia; Eguiguren, Gonzalo J. (1979)
      We describe 20 patients with a chronic polymorphic eruption; they shared clinical, histopathological, and therapeutic features of both dermatitis herpetiformis and bullous pemphigoid (BP). In 14 of these 20 cases, direct ...
    • Honeyman Mauro, Juan; Honeyman, A. R.; de La Parra, M.; Pinto, A.; Eguiguren, G. J. (1979)
      The authors describe 20 patients with a chronic polymorphic eruption; they shared clinical, histopathological, and therapeutic features of both dermatitis herpetiformis and bullous pemphigoid (BP). In 14 of these 20 cases, ...